Fiorino G - Search Results

1

Evaluating the pharmacokinetics of upadacitinib for the treatment of moderate-to-severe Crohn's disease.

Faggiani I, D'Amico F, Bernardi F, Bencardino S, Allocca M, Furfaro F, Parigi TL, Zilli A, Fiorino G, Peyrin-Biroulet L, Danese S. Faggiani I, et al. Among authors: fiorino g. Expert Opin Drug Metab Toxicol. 2024 May;20(5):297-305. doi: 10.1080/17425255.2024.2349711. Epub 2024 May 13. Expert Opin Drug Metab Toxicol. 2024. PMID: 38712496 Review.

2

Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner?

Fiorino G, Rovida S, Correale C, Malesci A, Danese S. Fiorino G, et al. Curr Drug Targets. 2010 Feb;11(2):249-60. doi: 10.2174/138945010790309975. Curr Drug Targets. 2010. PMID: 20210771 Review.

3

Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease.

Fiorino G, Correale C, Fries W, Repici A, Malesci A, Danese S. Fiorino G, et al. Expert Rev Clin Immunol. 2010 Jul;6(4):567-72. doi: 10.1586/eci.10.40. Expert Rev Clin Immunol. 2010. PMID: 20594130

4

Adalimumab in ulcerative colitis: hypes and hopes.

Fiorino G, Peyrin-Biroulet L, Repici A, Malesci A, Danese S. Fiorino G, et al. Expert Opin Biol Ther. 2011 Jan;11(1):109-16. doi: 10.1517/14712598.2011.541435. Expert Opin Biol Ther. 2011. PMID: 21133817 Review.

5

Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease.

Rutella S, Fiorino G, Vetrano S, Correale C, Spinelli A, Pagano N, Arena V, Maggiano N, Repici A, Malesci A, Danese S. Rutella S, et al. Among authors: fiorino g. Am J Gastroenterol. 2011 Apr;106(4):762-70. doi: 10.1038/ajg.2011.48. Epub 2011 Mar 1. Am J Gastroenterol. 2011. PMID: 21364546

6

Biological therapy for ulcerative colitis: what is after anti-TNF.

Fiorino G, Cesarini M, Danese S. Fiorino G, et al. Curr Drug Targets. 2011 Sep;12(10):1433-9. doi: 10.2174/138945011796818225. Curr Drug Targets. 2011. PMID: 21466492 Review.

7

Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study.

Fiorino G, Peyrin-Biroulet L, Naccarato P, Szabò H, Sociale OR, Vetrano S, Fries W, Montanelli A, Repici A, Malesci A, Danese S. Fiorino G, et al. Inflamm Bowel Dis. 2012 Jun;18(6):1042-7. doi: 10.1002/ibd.21800. Epub 2011 Jun 14. Inflamm Bowel Dis. 2012. PMID: 21674732 Clinical Trial.

8

Familial aggregation in inflammatory bowel disease: is it genes or environment?

Nunes T, Fiorino G, Danese S, Sans M. Nunes T, et al. Among authors: fiorino g. World J Gastroenterol. 2011 Jun 14;17(22):2715-22. doi: 10.3748/wjg.v17.i22.2715. World J Gastroenterol. 2011. PMID: 21734779 Free PMC article. Review.

9

Risk of postoperative recurrence and postoperative management of Crohn's disease.

Spinelli A, Sacchi M, Fiorino G, Danese S, Montorsi M. Spinelli A, et al. Among authors: fiorino g. World J Gastroenterol. 2011 Jul 21;17(27):3213-9. doi: 10.3748/wjg.v17.i27.3213. World J Gastroenterol. 2011. PMID: 21912470 Free PMC article. Review.

10

MRI in Crohn's disease--current and future clinical applications.

Fiorino G, Bonifacio C, Malesci A, Balzarini L, Danese S. Fiorino G, et al. Nat Rev Gastroenterol Hepatol. 2011 Nov 22;9(1):23-31. doi: 10.1038/nrgastro.2011.214. Nat Rev Gastroenterol Hepatol. 2011. PMID: 22105109 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters